FENOCAN Switzerland has announced the creation of new Chemotype IV Cannabis varieties – meaning high CBG contents of up to 15% with almost no detectable traces of THC – which makes these varieties suitable for cultivation in basically any jurisciction and market worldwide. The first badges of feminized FENOCAN CBG seeds will be availabe from April 2020.